首页 | 本学科首页   官方微博 | 高级检索  
检索        

覆膜支架在经颈静脉门腔分流术中的应用
引用本文:ZHAO Jian-bo,李彦豪,John A.Kaufman,Robert E.Barton.覆膜支架在经颈静脉门腔分流术中的应用[J].中华放射学杂志,2008,42(8).
作者姓名:ZHAO Jian-bo  李彦豪  John A.Kaufman  Robert E.Barton
作者单位:1. Department of linterventional Radiology,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
2. 南方医科大学南方医院介入放射科,广州,510515
3. 美国俄勒冈州健康生命科技大学Dotter介入放射学研究所
摘    要:目的 评价经颈静脉肝内门腔分流术(TIPS)专用覆膜支架(Viatorr支架)在TIPS中的应用价值.方法 回顾性分析37例在美国俄勒冈州健康生命科技大学Dotter介入放射学研究所采用Viatorr支架行TIPS治疗的患者资料,随访时间为(15.2±9.3)个月(3-42个月).TIPS指征包括门静脉高压相关性的急慢性消化道出血,经药物及内镜治疗无效者17例;顽固性肝源性胸、腹水18例,Budd-Chiari综合征2例.采用配对t检验比较手术前后门腔静脉压力差(PSG)的变化,以Kaplan-Meier曲线分析支架开通率.结果 37例共置入41枚Viatorr支架,其中3枚直径为8 mm,38枚为10 mm,支架带膜长度为4~8 cm,无相关手术并发症.PSG由术前的(22.4±8.4)mm Hg(1 mm Hg=0.133 kPa)降为(8.1±3.2)mm Hg,差异有统计学意义(t=12.754,P<0.01).17例出血患者术后出血均停止,1例于术后17个月复发.18例严重顽固性腹水及肝性胸水患者中,4例术后腹水不消退,其余14例随访期间有2例腹水复发.2例(5.4%)发生分流道阻塞,Kaplan-Meier曲线分析结果显示1年的开通率为97.0%.术后1个月内无病死患者,2例分别于术后3个月及15个月死于多器官功能衰竭,晚期病死率为5.4%,死亡前1周内复查支架均通畅.肝移植患者5例(13.5%).结论 Viatorr支架能明显提高TIPS术后开通率,选择合适的支架,采用正确的释放技术能进一步提高疗效,但长期效果评价尚需验证.

关 键 词:高血压  门静脉  支架  放射学  介入性

Stent-grafts in transjugular intrahepatic portosystemic shunts
ZHAO Jian-bo,LI Yan-hao,Kenneth J.Kolbeck,Frederick S.Keller,John A.Kaufman,Robert E.Barton,Bryan D.Petersen.Stent-grafts in transjugular intrahepatic portosystemic shunts[J].Chinese Journal of Radiology,2008,42(8).
Authors:ZHAO Jian-bo  LI Yan-hao  Kenneth JKolbeck  Frederick SKeller  John AKaufman  Robert EBarton  Bryan DPetersen
Abstract:Objective To retrospectively evaluate the efficacy of polytetrafluorothylene covered nitinol stent graft (Viatorr, Gore, Flagstaff Arizona, USA) in transjugular intrahepatic partosystemic shunt (TIPS). Methods Thirty-sevan consecutive patients underwent a TIPS procedure between May 2004 and June 2006 at the Dotter Interventionsl Institute in Portland, Oregon, USA. The average follow-up time was (15.2±9.3)months. Indications for the procedure included recurrent varieeal bleeding after attempted endoscopic management (n=17), refractory ascites or hydrothorax ( n = 18 ), and Budd-Chiari syndrome (n = 2). The t test was used for statistics. Results Forty-one stent-grafts were implanted in 37 patients, 3 of the devices were 8 mm in diameter and 38 were 10 mm. The covered stent length varied from 4 to 8 cm without complications. Portosystemic gradient (PSG) decresed significantly from (22.4±8.4) mm Hg (1 nun Hg=0.133 kPa) to(8.1±3.2)mm Hg, (t = 12.754,P <0.01). During the follow-up period, Variceal bleeding recurrence occurred in 1 of 17 patients and for ascites or hydrothorax, two of 14 patients. Shunt occlusion occurred in 2 of 37 (5.4%) patients (4 and 17 months post-shunt). The 1-year primary patency rate was 97.0%. Two patients died from multisystem organ failure (MSOF) with a patent stent-graft during the follow-up period. Five patients were excluded from the evaluation after liver transplantation. Conclusion TIPS created with a PTFE-covered stent (Viatorr) showed favorable patency rate and low complication rates.
Keywords:Hypertension  portal  Stents  Radiology  interventional
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号